Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

WIB-Connecticut 3.8 Initiative

The 3.8 Initiative, named for the March 8 International Women's Day, seeks to increase start-up board leadership for women in the Connecticut area's life science and health tech innovation ecosystem.

The three key pillars of the program include:

  1. A supportive network of women leaders in the health tech community
  2. A curriculum of startup board fundraising diligence areas correlating with individual gaps in training, and experiential opportunities for board readiness
  3. Facilitation of board seat placement for our cohort graduates by working with local VCs and incubators

Each cohort participates in several workshops and engages with subject matter experts outlining content relevant to startup board governance and leadership seminars.

Our Curriculum Focus

  • Founders, Incorporation & Equity
  • Team/Leadership
  • Scientific Data, Regulatory & Reimbursement
  • IP/Licensing
  • Basics of Startup Finances
  • Competition & Market Opportunity
  • Capital Structure & Exit
  • Networking for Board Opportunities

Who Should Apply?

  • Emerging female leaders, including mid-career and senior women leaders with substantive experience within the life sciences industry
  • Those who are passionate about supporting life sciences startups by serving on their boards
  • Those with expertise in organizational areas of life science, including (but not limited to): operations, finance, R&D, marketing, digital strategy, regulatory, business development and licensing, fundraising, strategy, and legal
  • Functional leaders with prior experience in financial management of life sciences organizations

A pre-requisite for the program is a WIB membership. To learn more, contact the Connecticut chapter at:

2022 Cohort

Kathleen Adams
Entrepreneur in Residence
UCONN Ventures

Carrie Collins
Corporate Development

Lisa Delfini
Chief Financial Officer
Trevi Therapeutics

Carla Devillers
Chief Executive Officer
LeptoX Biopharma

Susan Gallipoli
Senior Director, Clinical Research Operations

Anjelica Gonzalez
Yale University

Stephanie Jacoby
Board Chair and Manager, Founding CEO

Michelle Johnson
Chief Executive Officer
Metrum Research Group

Katherine Kayser-Bricker
Chief Scientific Officer
Halda Therapeutics 

Lisa Sinclair
SVP, Corporate Operations

Erika Smith
Chief Executive Officer
ReNetX Bio

Susan Sobolov

In-Kind Sponsor

Program Co-founded by


Women In Bio is an organization of professionals committed to promoting careers, leadership, and entrepreneurship of all women in the life sciences.

WIB membership and events are inclusive of all who support our mission.

(877) 717-5273


This website is powered by